AI generated stock image.
(AI generated stock image.)

Canada’s main stock index ended the week higher thanks to a boost driven by gains among mining and financial shares. The TSX crossed the 22,700.00 point for the first time in intraday trading. Healthcare and energy were the only lagging sectors.

A slew of U.S. banks kicked off earnings season, helping markets rebound after recent struggles where the S&P 500 had its worst performance since April in the previous session, after logging record close after record close earlier this week. The dip on Wall Street was mainly because of a rotation out of mega-cap technology stocks. The Dow Jones crossed the 40,000 mark for the first time since May.

TSX22,673.52+129.39TSX
TSXV593.70+7.15TSXV
CSE169.99+0.08CSE
DJIA40,000.90+247.15DJIA
NASDAQ18,398.44+115.04NASDAQ
S&P 5005,612.76+28.22S&P 500

The Canadian dollar traded for 73.37 cents U.S. compared with 73.34 cents U.S. on Thursday.

U.S. crude futures traded $0.16 lower at $82.46 a barrel, and the Brent contract lost $0.21 to $85.19 a barrel.

The price of gold was down US$1.13 to US$2,414.43.

In world markets, the Nikkei was down 1,033.34 points to 41,190.68, the Hang Seng was up 461.05 points to 18,293.38, the FTSE was up 29.57 points to 8,252.91, and the DAX was up 213.62 points to 18,748.18.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top image: AI generated stock picture.)

More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.